- Home
- Articles
- north america
- administration set
Administration Set Articles & Analysis
2 articles found
Limiting Residual Host Cell DNA: The World Health Organization (WHO), U.S. Food and Drug Administration (FDA), and European Pharmacopoeia recommend risk assessment based on cell matrix properties and product use. ...
Availability of SC Therapeutics – To date, the number of therapeutics marketed for SC administration is limited despite the advantages SC has over IV administration. ...
